Form Type: 4

SEC EDGAR Link
Accession Number:0000874015-20-000006
Date:2020-01-02
Issuer: IONIS PHARMACEUTICALS INC (IONS)
Original Submission Date:

Reporting Person:

BENNETT C FRANK
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT CARLSBAD, CA 92010

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 60.89 2020-01-02 deemed execution date A 48,626 (a) 2021-01-02 2027-01-01 common stock 48,626 $60.89 48,626 direct
Footnotes
IDfootnote
f1 grant on 01/02/2020 to reporting person of stock options under the ionis pharmaceuticals, inc. amended and restated 2011 equity incentive plan. following this transaction, the option was exercisable as to 0 shares on 01/02/2020. 25% of the shares subject to the option will vest and become exercisable on 01/02/2021. thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.
WhaleWisdom Logo

Elevate your investments